SHERIDAN, WYOMING – May 8, 2025 – Sennheiser has unveiled its latest innovation, the ACCENTUM Open, a true wireless earbud designed for multitaskers who need both clear sound and awareness of their surroundings. Combining Sennheiser's renowned sound tuning with an open, non-occlusive fit, the ACCENTUM Open provides a simple and efficient way to stay connected to both entertainment and the outside world.

Designed for Modern Multitaskers

The ACCENTUM Open was built with the user’s lifestyle in mind, offering easy-to-use features that enhance productivity and enjoyment. “ACCENTUM Open was designed to complement your busy life—not complicate it,” said Friederike Menking, Product Manager at Sennheiser. “Whether you are listening to music, catching up on a podcast at your desk, or checking in with your friends on your way to the train, the ease of use is second only to the sound.”

SHERIDAN, WYOMING – May 8, 2025 – Hansaton, a leading name in innovative hearing solutions, has unveiled the Hansaton Essenz platform, introducing the first product in the lineup: sound E-R, a cutting-edge receiver-in-canal (RIC) hearing aid. Designed to provide unparalleled sound quality from the very first use, the sound E-R promises exceptional comfort, reliability, and ease of use. Featuring a sleek, modern design and a convenient magnetic charger, this hearing aid is the perfect companion for those on the go or at home.

The Power Behind the Sound E-R: A Groundbreaking Platform

At the heart of the Hansaton Essenz platform are three key components that define the brand’s commitment to quality, performance, and user experience:

SHERIDAN, WYOMING – May 8, 2025 – Cochlear North America has been recognized with the prestigious Silver Award from Cigna's Healthy Workforce Designation for 2024. This esteemed honor reflects the company's ongoing commitment to promoting a supportive and healthy work environment for its employees. With a focus on mental health, physical fitness, and work-life balance, Cochlear North America's wellness initiatives continue to set a benchmark for employee well-being.

Recognition for Employee Wellness Excellence

The Silver Award from Cigna’s Healthy Workforce Designation acknowledges organizations for their comprehensive efforts to support the health and well-being of their workforce. Cochlear North America’s dedication to fostering a thriving workplace is evident in its robust wellness programs, which focus on holistic employee care, including mental health resources, physical fitness initiatives, and a culture that emphasizes work-life balance.

SHERIDAN, WYOMING – May 7, 2025 – Convatec, a global leader in medical technologies focused on chronic condition management, has received regulatory approval for ConvaNiox™, a first-of-its-kind nitric oxide-generating multimodal dressing technology. This innovative product aims to significantly improve outcomes for patients with diabetic foot ulcers (DFUs), offering a powerful solution to an underserved segment of the wound care market.

The full launch of ConvaNiox™ is set for 2026, with an initial rollout scheduled for later this year in key European markets. This new technology combines the potent antimicrobial and antibiofilm properties of nitric oxide to accelerate healing in chronic wounds, particularly DFUs. In clinical trials, ConvaNiox™ demonstrated remarkable results, healing DFUs 60% faster than standard treatments.

SHERIDAN, WYOMING – May 7, 2025 – Convatec, a leading provider of medical products and technologies, has expressed its support for the postponement of Local Coverage Determinations (LCDs) for skin substitutes in the United States until January 2026. This delay, made by the Centers for Medicare & Medicaid Services (CMS), ensures that Medicare patients in the US will continue to have access to InnovaMatrix®, a trusted product for treating diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).

SHERIDAN, WYOMING – May7, 2025 – Drägerwerk AG & Co. KGaA has shown significant growth in its order intake during the first quarter of 2025, marking a strong start to the year despite a seasonally weaker operating result. With order intake reaching approximately EUR 861 million, the company exceeded its prior-year figures by EUR 50 million. Net sales closely mirrored last year's numbers, while operating results remained narrowly positive, reflecting both challenges and opportunities across global markets.

SHERIDAN, WYOMING – May 7, 2025 – Dräger, a global leader in safety technology, has launched the Alcotest 7000, an advanced alcohol screening device that is set to redefine safety protocols in law enforcement, Department of Transportation (DOT) compliance, and workplace safety initiatives. This innovative new product comes with dual-function capability, designed to meet the evolving needs of both criminal justice and safety-sensitive industries. The Alcotest 7000 is poised to enhance accuracy, streamline operations, and contribute to safer roads and workplaces.

Dual-Mode Testing for Enhanced Flexibility

The Alcotest 7000 is a versatile device that offers two modes of operation, allowing it to be used in various environments for a broad range of applications. Whether it’s in high-volume screening situations or precise, individual assessments, the Alcotest 7000 ensures reliable and accurate results every time.

SHERIDAN, WYOMING – May 7, 2025 – Dräger, a global leader in medical and safety technology, has been awarded a significant five-year contract by the U.S. Department of Veterans Affairs (VA) under the Non-Expendable (NX) Equipment Program. This contract focuses on providing cutting-edge surgical lighting systems and equipment boom solutions to VA medical facilities, streamlining procurement and enhancing operational efficiency across the healthcare system.

Strategic Importance of the VHA Contract

The newly awarded contract (#36C10G24D0105) will allow Veterans Health Administration (VHA) medical centers to access Dräger's advanced surgical lighting and equipment booms via the National Equipment Catalog (NEC). By offering a streamlined purchasing process, this contract will not only support the operational needs of VA facilities but also drive long-term value in terms of cost efficiency and clinical outcomes.

SHERIDAN, WYOMING – May 7, 2025 – Mindray, a global leader in medical technologies, has announced the launch of its new-generation FA-N Series, an advanced automatic microbial culture system designed to transform the diagnosis of bloodstream infections. This cutting-edge system offers optimized workflows, faster detection times, and enhanced accuracy, addressing key challenges faced by clinical microbiologists and improving patient outcomes.

SHERIDAN, WYOMING – May 7, 2025 – Terumo Corporation, a global leader in medical technology, has unveiled its "Terumo Group Statement on Nature," a comprehensive guideline aimed at enhancing the company's commitment to the conservation and restoration of natural environments. This initiative is a strategic step in Terumo's ongoing efforts to reduce its environmental footprint and promote sustainability within its operations and value chain.

Strengthening Environmental Responsibility

With the establishment of the "Terumo Group Statement on Nature," the company emphasizes its corporate responsibility to mitigate the environmental impact of its business activities. Terumo acknowledges its reliance on natural resources such as water and recognizes the broader impacts of its operations on biodiversity and ecosystems. By focusing on the reduction of environmental harm and promoting nature conservation, Terumo aligns its operations with global sustainability trends.